Cracking The Code: Understanding Analyst Reviews For Exact Sciences
Cracking The Code: Understanding Analyst Reviews For Exact Sciences
破解密碼：理解分析師對精密科學的評價
In the preceding three months, 9 analysts have released ratings for Exact Sciences (NASDAQ:EXAS), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有9位分析師發佈了Exact Sciences（納斯達克股票代碼：EXAS）的評級，提出了從看漲到看跌的各種觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Exact Sciences, revealing an average target of $74.0, a high estimate of $85.00, and a low estimate of $67.00. Observing a downward trend, the current average is 12.8% lower than the prior average price target of $84.86.
分析師已經爲Exact Sciences設定了12個月的目標股價，顯示平均目標股價爲74.0美元，最高估計爲85.00美元，低估值爲67.00美元。從下降趨勢來看，目前的平均價格比之前的平均目標價84.86美元低12.8％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
The perception of Exact Sciences...
通過分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。